Drug maker AstraZeneca, which is one of several companies developing a COVID-19 vaccine, paused its phase three trial on Tuesday after a participant came down with an unexplained illness. It’s not known, however, what happened to the patient or if the illness is linked to the vaccine.
- AstraZeneca expects coronavirus vaccine result by year-end if trials resume soon
- Why a pause on AstraZeneca’s coronavirus vaccine trial isn’t entirely bad news
- AstraZeneca pauses COVID-19 vaccine trial after unexplained illness in U.K.